Inventor · disambiguated record
Rasmus Rojkjaer
Also filed as: ROJKJAER RASMUS
3 granted patents·33 pending applications·71 citations·filing 2002–2007
74Inventor score
Top patents by PatentIndex Score
36 records- 0187US7125846B2Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Oct 24, 2006·37 cites·19 claims
- 0284US7078479B2Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Jul 18, 2006·26 cites·17 claims
- 0376US7291587B2Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Nov 6, 2007·8 cites·68 claims
- 0467US2006276398A1Combined use of factor VII polypeptides and factor VIII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 0566US2006211621A1Combined use of factor VII polypeptides and factor IX polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 0664US2007219135A1Pharmaceutical Composition Comprising Factor VII Polypeptides and PAI-1 PolypeptideNOVO NORDISK HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 0762US2008069810A1Pharmaceutical Composition Comprising Factor VII Polypeptides and TAFI PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 0861US2008076702A1Combined Use of Factor VII Polypeptides and Factor VIII PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 0961US2008075711A1Combined Use of Factor VII Polypeptides and Factor IX PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 1059US2006030531A1Pharmaceutical composition comprising factor VII polypeptide and PAI-1 polypeptideNOVO NORDISK HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 1157US2007280920A1PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A FACTOR XIIINOVO NORDISK HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 1255US2005266006A1Pharmaceutical composition comprising factor VII polypeptides and tissue plasminogen inhibitorsNOVO NORDISK HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 1355US2004258690A1Pharmaceutical composition comprising factor VII polypeptides and protein S inhibitorsFiled 2004·Application pending·0 cites
- 1455US2008058266A1Pharmaceutical Compositions Comprising Factor VII Polypeptides and Factor XI PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 1555US2005267014A1Pharmaceutical composition comprising factor VII polypeptides and tranexamic acidNOVO NORDISK HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 1655US2008102064A1Pharmaceutical Composition Comprising Factor VII Polypeptides and Protein C InhibitorsNOVO NORDISK HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 1754US2003199444A1Combined use of VII polypeptides and factor VIII polypeptidesFiled 2003·Application pending·0 cites
- 1854US2006199766A1Pharmaceutical composition comprising a factor VIIa and a factor XIIINOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 1954US2008057059A1Pharmaceutical Composition Comprising Factor VII Polypeptides and Protein S InhibitorsNOVO NORDISK HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 2053US2009221484A1Use of Factor VII Polypeptides for NeuroprotectionNOVO NORDISK AS·Filed 2006·Application pending·0 cites
- 2153US2003119723A1Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptidesFiled 2002·Application pending·0 cites
- 2252US2003040480A1Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptidesFiled 2002·Application pending·0 cites
- 2351US2004006020A1Pharmaceutical composition comprising a factor VII polypeptide and epsilon-aminocaproic acidFiled 2003·Application pending·0 cites
- 2451US2008075709A1Pharmaceutical Composition Comprising Factor VII Polypeptides And Thrombomodulin PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 2550US2003119743A1Pharmaceutical composition comprising factor VII polypeptides and tissue plasminogen inhibitorsFiled 2002·Application pending·0 cites
- 2650US2003124118A1Pharmaceutical composition comprising factor VII polypeptides and protein S inhibitorsFiled 2002·Application pending·0 cites
- 2750US2006013812A1Pharmaceutical composition comprising factor VII polypeptides and protein C inhibitorsNOVO NORDISK HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 2850US2003118580A1Pharmaceutical composition comprising factor VII polypeptides and thrombomodulin polypeptidesFiled 2002·Application pending·0 cites
- 2949US2007027077A1Pharmaceutical compositions comprising factor VII polypeptides and factor XI polypeptidesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 3047US2006025336A1Pharmaceutical compositions comprising combinations of factor VII polypeptides and aprotinin polypeptidesNOVO NORDISK AS·Filed 2005·Application pending·0 cites
- 3146US2009053193A1Use of Factor VIIa for the Treatment of Burn TraumaNOVO NORDISK HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 3245US2003203845A1Combined use of factor VII polypeptides and factor IX polypeptidesFiled 2002·Application pending·0 cites
- 3345US2003118582A1Pharmaceutical composition comprising factor VII polypeptides and protein C inhibitorsFiled 2002·Application pending·0 cites
- 3444US2003119741A1Pharmaceutical composition comprising factor VII polypeptides and aprotinin polypeptidesFiled 2002·Application pending·0 cites
- 3543US2004006021A1Pharmaceutical composition comprising factor Vll polypeptides and tranexamic acidFiled 2003·Application pending·0 cites
- 3642US2005181978A1Therapeutic use of factor XIFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rasmus Rojkjaer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →